🔎 Trials Near Me

Hjem › Kreft (alle typer) › Wisconsin › Madison

Kliniske studier for Kreft (alle typer) i Madison, WI

14 studier for Kreft (alle typer) søker deltakere på steder i og rundt Madison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study of ASP3082 in Adults With Advanced Solid Tumors

RekruttererFase 1
  • University of Wisconsin Hospital, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05382559

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

RekruttererFase 3
  • University of Wisconsin /ID# 279909, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07365241

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RekruttererFase 2/3
  • University Of Wisconsin, Madison
Alle aldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT03435796

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

RekruttererFase 2
  • University of Wisconsin at Madison, Madison
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034

Evaluating the Communication Between Patients and Providers in Cancer Clinics

Rekrutterer
  • University of Wisconsin - Madison, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06985953

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

RekruttererFase 1/2
  • University of Wisconsin, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06634589

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

Project: Every Child for Younger Patients With Cancer

RekruttererObservasjonsstudie
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • University of Wisconsin, Carbone Cancer Center, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • University of Wisconsin- Madison, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626

Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery

RekruttererObservasjonsstudie
  • UW Health, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT07532083

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

RekruttererFase 1
  • University of Wisconsin, Madison
Alder 18 og eldre · Menn · Oppdatert 9. jul. 2026 · NCT07103018

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Rekrutterer
  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Alder 18 til 75 · Alle kjønn · Oppdatert 17. jun. 2026 · NCT05486572

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • University of Winsconsin Carbone Cancer Center-Eastpark medical Center, Madison
  • University of Wisconsin Carbone Cancer Center, Madison
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883

Kreft (alle typer)-studier i andre byer

Andre studier i Madison

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.